Gastón Picchio

Telaprevir for Retreatment of HCV Infection

Stefan Zeuzem, Pietro Andreoné, Stanislas Pol et al. · New England Journal of Medicine · 2011 · 1.5K citations · Full text

Pharmacy, Infectious Diseases, Pharmacotherapy +16

Simeprevir plus sofosbuvir, with or without ribavirin, to treat chronic infection with hepatitis C virus genotype 1 in non-responders to pegylated interferon and ribavirin and treatment-naive patients: the COSMOS randomised study

Eric Lawitz, Mark Sulkowski, Reem Ghalib et al. · The Lancet · 2014 · 818 citations

Pharmacy, Infectious Diseases, Pharmacotherapy +16

TMC278, a Next-Generation Nonnucleoside Reverse Transcriptase Inhibitor (NNRTI), Active against Wild-Type and NNRTI-Resistant HIV-1

Hilde Azijn, Ilse Tirry, Johan Vingerhoets et al. · Antimicrobial Agents and Chemotherapy · 2009 · 294 citations · Full text

Life Sciences, Pharmacology, Pharmacotherapy +17

Establishment of B-Cell Lymphoma Cell Lines Persistently Infected with Hepatitis C Virus In Vivo and In Vitro: the Apoptotic Effects of Virus Infection

Vicky M.-H. Sung, Shigetaka Shimodaira, Alison L. Doughty et al. · Journal of Virology · 2003 · 248 citations · Full text

Medicine, Cell Biology, Infectious Diseases +17

Neutralizing Antibodies Have Limited Effects on the Control of Established HIV-1 Infection In Vivo

Pascal Poignard, Rebecca Sabbe, Gastón Picchio et al. · Immunity · 1999 · 239 citations · Full text

Veterinary Medicine, Immunology, Infectious Diseases +11